Stat : Canadian Drug Price Board Member Resigns Over Government Failure Вђto Support Real Changeвђ™ - Mr Validity -
In February 2023, , a member of Canada’s Patented Medicine Prices Review Board (PMPRB) , resigned in a blistering letter to the federal government. Herder , a health law expert at Dalhousie University , accused the Liberal government of failing to support "real change" and undermining the regulator's independence to favor the pharmaceutical industry. Key Reasons for Resignation
Herder’s departure was prompted by what he described as the government’s "unwillingness to support real change" in drug pricing reform. His specific grievances included: In February 2023, , a member of Canada’s
: He pointed to the government's decision not to appeal a Quebec Court of Appeal ruling that struck down several core pricing reforms, effectively "eviscerating" the government’s own policy. His specific grievances included: : He pointed to
: Herder stated the government’s actions were "largely indistinguishable in form and substance from industry talking points," leaving the regulator in an "endless tunnel with no light". Context and Fallout In February 2023